Acelyrin Inc [SLRN] stock prices are saw in change for the day to $2.13 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The SLRN shares have gain 12.70% over the last week, with a monthly amount glided 7.04%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Acelyrin Inc [NASDAQ: SLRN] stock has seen the most recent analyst activity on August 14, 2024, when H.C. Wainwright downgraded its rating to a Neutral and also revised its price target to $6 from $18. Previously, Wells Fargo upgraded its rating to Overweight on July 08, 2024, and kept the price target unchanged to $13. On December 13, 2023, Wells Fargo initiated with a Equal Weight rating and assigned a price target of $11 on the stock. Citigroup started tracking the stock assigning a Neutral rating and suggested a price target of $8 on December 08, 2023. Morgan Stanley downgraded its rating to a Equal-Weight but $19 remained the price target by the analyst firm on September 13, 2023. H.C. Wainwright started tracking with a Buy rating for this stock on September 05, 2023, and assigned it a price target of $44. In a note dated May 30, 2023, TD Cowen initiated an Outperform rating.
The stock price of Acelyrin Inc [SLRN] has been fluctuating between $1.85 and $8.89 over the past year. Currently, Wall Street analysts expect the stock to reach $15 within the next 12 months. Acelyrin Inc [NASDAQ: SLRN] shares were valued at $2.13 at the most recent close of the market. An investor can expect a potential return of 604.23% based on the average SLRN price forecast.
Analyzing the SLRN fundamentals
Gross Profit Margin for this corporation currently stands at -0.32% with Operating Profit Margin at -2022.04%, Pretax Profit Margin comes in at -1592.8%, and Net Profit Margin reading is -1592.8%. To continue investigating profitability, this company’s Return on Assets is posted at -0.43, Equity is -0.44 and Total Capital is -0.63. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.10 points at the first support level, and at 2.07 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.17, and for the 2nd resistance point, it is at 2.21.
Ratios To Look Out For
It’s worth pointing out that Acelyrin Inc [NASDAQ:SLRN]’s Current Ratio is 7.15. On the other hand, the Quick Ratio is 7.15, and the Cash Ratio is 2.59.
Transactions by insiders
Recent insider trading involved Becker Daniel J., Director, that happened on Jul 17 ’24 when 1.0 shares were sold. Chief Executive Officer, Lin Shao-Lee completed a deal on Apr 01 ’24 to sell 9961.0 shares. Meanwhile, Chief Executive Officer Lin Shao-Lee sold 15701.0 shares on Feb 20 ’24.
